Simplified Approaches to Medium-Sized Heterocycles for the Synthesis of Bioactive Small Molecules
用于合成生物活性小分子的中型杂环的简化方法
基本信息
- 批准号:9287216
- 负责人:
- 金额:$ 29.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptionAlcoholsAminationAminesArchitectureBenzazepinesCationsChargeChemicalsCommunitiesComplexDevelopmentEthersGoalsInvestigationIodineLaboratoriesLeadLibrariesLigandsLiteratureMethodologyMethodsMotivationNatural ProductsNitrogenOrganic SynthesisOxygenPeriodicityPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePodophyllotoxinProcessProduct RPublic HealthReactionReagentResearchTherapeuticToxic effectTransition ElementsTubulinWorkalcohol availabilityalkaloid skeletonanalogbioactive natural productschemotherapyclinical developmentcostdrug discoveryinventionmethod developmentnoveloxepanescaffoldsmall molecule
项目摘要
PROJECT SUMMARY
The goal of this proposal is to develop simplified approaches to the construction of diverse medium-
sized oxygen and nitrogen heterocycles that can be applied to the synthesis and complexity-building
diversification of bioactive small molecules. Medium-ring heterocycles are ubiquitous in naturally occurring
bioactive molecules, however these scaffolds remain largely absent from pharmaceutical drug scaffolds due to
challenges associated with their synthesis. In order to address rising concerns regarding the lack of chemical
space explored by current therapeutic molecules, we propose methods that enable the use of readily available
alcohols and amines as functional handles for the facile synthesis of medium-sized heterocycles. Preliminary
work in our laboratory has discovered a novel electrophilic heteroatom rearrangement of benzylic alcohols
facilitated by a unique class of (poly)cationic hypervalent iodine reagents that allows direct access to diverse
medium-ring ethers. The first aim of this proposal is the continued development of this novel transformation to
include secondary and tertiary alcohols as well as amine substrates, providing a general platform for medium-
ring heterocycle synthesis. The second aim is the further development of our enabling (poly)cationic λ3-
iodanes, both through detailed reactivity studies as well as novel derivative syntheses, in order to facilitate their
adoption as broadly utilized synthetic reagents. We will also employ these reagents as a novel manifold for the
synthesis of chiral hypervalent iodine scaffolds. The third aim of this proposal will utilize our methodology as an
enabling platform for complex medium-sized ether analogues of the promising chemotherapeutic lead
podophyllotoxin, a compound that has seen little clinical development to date due to limited tolerance for
traditional medicinal chemistry diversification. The work is significant because the development of simplified
approaches to medium-ring heterocycles will expand the chemical space available for drug discovery by
providing previously inaccessible analogues and facilitating more rapid syntheses of complex bioactive natural
products. Furthermore, the development of promising (poly)cationic λ3-iodanes will provide the synthetic
community with a powerful new toolkit of synthetic reagents.
项目总结
这项建议的目标是制定简化的方法,以建设多样化的媒体-
可用于合成和构建络合物的大小的氧和氮杂环
生物活性小分子的多样化。中环杂环化合物在天然产物中普遍存在
生物活性分子,然而,这些支架仍然很大程度上不存在于药物支架中,因为
与它们的合成相关的挑战。为了解决人们对缺乏化学品的日益加剧的担忧
目前的治疗分子所探索的空间,我们提出的方法使随时可用的
醇和胺作为功能手柄,可方便地合成中等大小的杂环。初步
我们实验室的工作发现了一种新的苄基醇的亲电杂原子重排
由一类独特的(聚阳离子)高价碘试剂促进,允许直接访问各种
中环醚。这项提议的第一个目标是继续发展这一新颖的转变,以
包括仲醇和叔醇以及胺底物,为中间体提供了一个通用平台
环杂环合成。第二个目标是进一步开发我们的使能(聚)阳离子λ3-
通过详细的反应性研究和新的衍生物合成,以促进其
作为广泛使用的合成试剂而采用。我们还将使用这些试剂作为一种新的歧管,用于
手性高价碘支架的合成。该提案的第三个目标将利用我们的方法作为
前景看好的化疗先导的复杂中型乙醚类似物的使能平台
鬼臼毒素,一种由于对鬼臼毒素的耐受性有限而迄今几乎没有临床应用的化合物
传统药物化学多样化。这项工作具有重要意义,因为它的开发简化了
中环杂环化合物的方法将通过以下方式扩大药物发现的可用化学空间
提供以前无法获得的类似物,并促进复杂生物活性天然产物的更快速合成
产品。此外,前景看好的(聚阳离子λ)3-碘烷的开发将为合成
拥有强大的合成试剂新工具包的社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Elizabeth Wengryniuk其他文献
Sarah Elizabeth Wengryniuk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sarah Elizabeth Wengryniuk', 18)}}的其他基金
Simplified Approaches to Medium-Sized Heterocycles for the Synthesis of Bioactive Small Molecules
用于合成生物活性小分子的中型杂环的简化方法
- 批准号:
9897570 - 财政年份:2017
- 资助金额:
$ 29.48万 - 项目类别:
Novel Zn(SO2R)2 Salts: Radical-Based Approaches to Functionalized Heteroarenes
新型 Zn(SO2R)2 盐:基于自由基的功能化杂芳烃方法
- 批准号:
8642534 - 财政年份:2013
- 资助金额:
$ 29.48万 - 项目类别:
Novel Zn(SO2R)2 Salts: Radical-Based Approaches to Functionalized Heteroarenes
新型 Zn(SO2R)2 盐:基于自由基的功能化杂芳烃方法
- 批准号:
8524710 - 财政年份:2013
- 资助金额:
$ 29.48万 - 项目类别:
相似海外基金
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
- 批准号:
24K16436 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
- 批准号:
10093543 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Collaborative R&D
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
- 批准号:
24K16488 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
- 批准号:
24K20973 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 29.48万 - 项目类别:
EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
- 批准号:
481560 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Operating Grants
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
- 批准号:
10075502 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
- 批准号:
10089082 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
EU-Funded
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
- 批准号:
2321091 - 财政年份:2023
- 资助金额:
$ 29.48万 - 项目类别:
Standard Grant














{{item.name}}会员




